Blackman Samuel C.'s Form 4 filing
Day One Biopharmaceuticals, Inc. (DAWN) · filed Nov 19, 2024
- Accession no.
- 0001415889-24-027234
- Filed
- Nov 19, 2024
- Trade date
- Nov 15-18, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $29.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blackman Samuel C.CIK 0001863676 | Officer (HEAD OF R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Common Stock | MOption exerciseAcquired | +1,187 | – | – | 1,058,722 | Direct | |
| Nov 15, 2024 | Common Stock | MOption exerciseAcquired | +1,437 | – | – | 1,060,159 | Direct | |
| Nov 15, 2024 | Common Stock | MOption exerciseAcquired | +6,062 | – | – | 1,066,221 | Direct | |
| Nov 18, 2024 | Common Stock | SSaleDisposed | −2,206 | $13.21 | −$29,141.26 | 1,064,015 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2024 | Common Stock | MOption exerciseDisposed | −1,187 | $0.00 | $0 | 4,756 | Direct | |
| Nov 15, 2024 | Common Stock | MOption exerciseDisposed | −1,437 | $0.00 | $0 | 11,504 | Direct | |
| Nov 15, 2024 | Common Stock | MOption exerciseDisposed | −6,062 | $0.00 | $0 | 72,752 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.